(Q36188333)

12 August 2017

1 reference

title

Gram-positive resistance: pathogens, implications, and treatment options: insights from the Society of Infectious Diseases Pharmacists (English)

1 reference

12 August 2017

main subject

gram-positive bacteria

0 references

author name string

Ronda L Akins

series ordinal

1

1 reference

12 August 2017

Krystal K Haase

series ordinal

2

1 reference

12 August 2017

language of work or name

English

0 references

publication date

1 July 2005

1 reference

12 August 2017

1 reference

12 August 2017

volume

25

1 reference

12 August 2017

issue

7

1 reference

12 August 2017

page(s)

1001-1010

1 reference

Methicillin-resistant Staphylococcus aureus clinical strain with reduced vancomycin susceptibility.

12 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.2005.25.7.1001

Vancomycin intermediate-resistant Staphylococcus aureus

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.2005.25.7.1001

Vancomycin-resistant Staphylococcus aureus isolate from a patient in Pennsylvania

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.2005.25.7.1001

Baseline Study To Determine In Vitro Activities of Daptomycin against Gram-Positive Pathogens Isolated in the United States in 2000-2001

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.2005.25.7.1001

National Nosocomial Infections Surveillance (NNIS) System Report, data summary from January 1992 through June 2003, issued August 2003.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.2005.25.7.1001

Survey of infections due to Staphylococcus species: frequency of occurrence and antimicrobial susceptibility of isolates collected in the United States, Canada, Latin America, Europe, and the Western Pacific region for the SENTRY Antimicrobial Surve

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.2005.25.7.1001

A polyclonal outbreak of predominantly VanB vancomycin-resistant enterococci in northeast Ohio. Northeast Ohio Vancomycin-Resistant Enterococcus Surveillance Program

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.2005.25.7.1001

Inactivated pbp4 in highly glycopeptide-resistant laboratory mutants of Staphylococcus aureus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.2005.25.7.1001

Vancomycin-resistant Staphylococcus aureus: a new model of antibiotic resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.2005.25.7.1001

Bactericidal activities of daptomycin, quinupristin-dalfopristin, and linezolid against vancomycin-resistant Staphylococcus aureus in an in vitro pharmacodynamic model with simulated endocardial vegetations

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.2005.25.7.1001

Antibacterial susceptibility of a vancomycin-resistant Staphylococcus aureus strain isolated at the Hershey Medical Center

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.2005.25.7.1001

Epidemiology and clonality of community-acquired methicillin-resistant Staphylococcus aureus in Minnesota, 1996-1998.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.2005.25.7.1001

Dissemination of new methicillin-resistant Staphylococcus aureus clones in the community

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.2005.25.7.1001

Phenotypic and molecular characterization of community occurring, Western Samoan phage pattern methicillin-resistant Staphylococcus aureus

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.2005.25.7.1001

Community-acquired methicillin-resistant Staphylococcus aureus infections in south Texas children

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.2005.25.7.1001

Mupirocin and Staphylococcus aureus: a recent paradigm of emerging antibiotic resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.2005.25.7.1001

Management of complications associated with totally implantable ports in patients with AIDS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.2005.25.7.1001

Emergence of a teicoplanin-resistant small colony variant of Staphylococcus epidermidis during vancomycin therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.2005.25.7.1001

Emergence of vancomycin resistance in coagulase-negative staphylococci

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.2005.25.7.1001

Selection of vancomycin- and teicoplanin-resistant Staphylococcus haemolyticus during teicoplanin treatment of S. epidermidis infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.2005.25.7.1001

Correlations between consumption of antibiotics and methicillin resistance in coagulase negative staphylococci.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.2005.25.7.1001

Biofilm testing of Staphylococcus epidermidis clinical isolates: low performance of vancomycin in relation to other antibiotics

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.2005.25.7.1001

Worldwide incidence, molecular epidemiology and mutations implicated in fluoroquinolone-resistant Streptococcus pneumoniae: data from the global PROTEKT surveillance programme.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.2005.25.7.1001

Tolerance to vancomycin in a multiresistant, Colombian isolate of Streptococcus pneumoniae.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.2005.25.7.1001

Isolation and characterization of vancomycin-tolerant Streptococcus pneumoniae from the cerebrospinal fluid of a patient who developed recrudescent meningitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.2005.25.7.1001

Occurrence and epidemiology of resistance to virginiamycin and streptogramins

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.2005.25.7.1001

Geographic variations and trends in antimicrobial resistance among Enterococcus faecalis and Enterococcus faecium in the SENTRY Antimicrobial Surveillance Program (1997–2000)

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.2005.25.7.1001

Clinical cure and survival in Gram-positive ventilator-associated pneumonia: retrospective analysis of two double-blind studies comparing linezolid with vancomycin

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.2005.25.7.1001

Linezolid (PNU-100766) versus vancomycin in the treatment of hospitalized patients with nosocomial pneumonia: a randomized, double-blind, multicenter study

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.2005.25.7.1001

Linezolid versus vancomycin for the treatment of methicillin-resistant Staphylococcus aureus infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.2005.25.7.1001

Linezolid resistance in clinical isolates of Staphylococcus aureus

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.2005.25.7.1001

Linezolid-resistant Enterococcus faecium isolated from a patient without prior exposure to an oxazolidinone: report from the SENTRY Antimicrobial Surveillance Program

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.2005.25.7.1001

Linezolid does not increase the risk of thrombocytopenia in patients with nosocomial pneumonia: comparative analysis of linezolid and vancomycin use.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.2005.25.7.1001

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.2005.25.7.1001

Once-daily dosing in dogs optimizes daptomycin safety

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.2005.25.7.1001

Evaluation of the in-vitro activity of the glycopeptide antibiotic LY333328 in comparison with vancomycin and teicoplanin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.2005.25.7.1001

Novel antibacterial agents for skin and skin structure infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.2005.25.7.1001

The pharmacokinetics of quinupristin/dalfopristin in laboratory animals and in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.2005.25.7.1001

Treatment of gram-positive nosocomial pneumonia. Prospective randomized comparison of quinupristin/dalfopristin versus vancomycin. Nosocomial Pneumonia Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.2005.25.7.1001

Intrapulmonary penetration of linezolid

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.2005.25.7.1001

Linezolid penetration into bone and joint tissues infected with methicillin-resistant staphylococci

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.2005.25.7.1001

Treatment of Staphylococcus epidermidis ventriculo-peritoneal shunt infection with linezolid

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.2005.25.7.1001

Pharmacokinetics and inflammatory fluid penetration of intravenous daptomycin in volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.2005.25.7.1001

Combining quinupristin/dalfopristin with other agents for resistant infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.2005.25.7.1001

Daptomycin synergy with rifampicin and ampicillin against vancomycin-resistant enterococci

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.2005.25.7.1001

Synergy of daptomycin with oxacillin and other beta-lactams against methicillin-resistant Staphylococcus aureus

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.2005.25.7.1001

10.1592/PHCO.2005.25.7.1001

21 January 2018

Identifiers

DOI

1 reference

12 August 2017

1 reference